about
Oral fumaric acid esters for psoriasisTopical treatments for cutaneous wartsOsmotic demyelination syndromeOral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessmentsVitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.Light therapies for acne.Angiosarcoma of the breast following surgery and radiotherapy for breast cancer.Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.Subacute cutaneous lupus erythematosus associated with radioiodine treatment.Incidence of primary cutaneous T-cell lymphoma in Wales.Widespread papules in a patient with human immunodeficiency virus. Papular mucinosis (PM) in association with HIV infection.Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years.Bexarotene therapy for mycosis fungoides and Sézary syndrome.Survey of dermatologists demonstrates widely varying approaches to perioperative antibiotic use: time for a randomized trial?The Hidradenitis Suppurativa Priority Setting Partnership.Erythematous plaque on the abdomen of an infant.Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swabNevoid dermal melanocytosis in the dermatome C3Acquired loss of hair pigment associated with a flexural dermatosisYellow papules and plaques on the face of a young girlFlat-topped erythematous papules on the fingers
P50
Q24187957-953DFD5F-7636-48B0-8081-45DFA6A91CBCQ24200667-A6A1F318-E8C7-4800-8504-49E879B25345Q24531458-756F2AEC-5FDB-4402-8AF2-7A4EF88EFC82Q28066898-11D53E98-357F-44A1-AFC2-096A138EF28BQ35019101-57311291-0D31-4ACA-BE82-91427F64786AQ36145236-5CBD7A15-D604-4BAF-94E4-87FCDF461EE4Q37303873-2B8FA08B-F466-4432-89F7-6D87149D353AQ37870281-EF017576-4DAF-4E6E-8EB4-ECE895A24B25Q41930225-BAF0874B-397A-4842-9DFC-6ADAE02F3FCFQ43629242-7B785ED4-C9DD-4B20-9E43-C98075F9292BQ45373156-FBF6DDE4-120F-4672-9A91-3B1B92EE7F02Q46077268-F4D64557-8DA9-4EB7-A39D-953CED53A927Q46119707-5524B547-532A-4661-9431-D7B302D1091BQ48372557-C7CABE36-81A6-49C0-9B9C-F6E176181747Q53276953-58810611-B8FA-4FAD-881F-95AE5DA9F6B5Q54688743-5B52BD18-F364-498C-B75B-A132FA665471Q82032758-CA6990B7-D452-46B4-99C0-7AEB758F9827Q83902391-A81AE068-30F6-4E9D-A444-447DE73C5FE9Q84299240-93757D9F-3B36-423B-9457-04A5A064A8D8Q84299261-43CEB239-DF77-4E7C-9161-6B5F25648763Q84344073-F943F9DC-3577-41AD-BB61-E92C4EB2CB2B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rachel Abbott
@ast
Rachel Abbott
@en
Rachel Abbott
@es
Rachel Abbott
@nl
راشيل أبوت
@ar
type
label
Rachel Abbott
@ast
Rachel Abbott
@en
Rachel Abbott
@es
Rachel Abbott
@nl
راشيل أبوت
@ar
prefLabel
Rachel Abbott
@ast
Rachel Abbott
@en
Rachel Abbott
@es
Rachel Abbott
@nl
راشيل أبوت
@ar
P106
P21
P31
P496
0000-0002-3415-7132